Royal London Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-83,038
| Closed | -$9.61M | – | 692 |
|
|
2023
Q3 | $9.61M | Buy |
83,038
+2,755
| +3% | +$319K | 0.03% | 369 |
|
|
2023
Q2 | $8.26M | Buy |
80,283
+4,437
| +6% | +$456K | 0.03% | 398 |
|
|
2023
Q1 | $8.28M | Sell |
75,846
-468
| -0.6% | -$51.1K | 0.03% | 366 |
|
|
2022
Q4 | $8.68M | Buy |
76,314
+5,524
| +8% | +$628K | 0.04% | 346 |
|
|
2022
Q3 | $4.38M | Sell |
70,790
-8,759
| -11% | -$542K | 0.02% | 458 |
|
|
2022
Q2 | $6.35M | Hold |
79,549
| – | – | 0.03% | 394 |
|
|
2022
Q1 | $8.37M | Buy |
79,549
+6,728
| +9% | +$708K | 0.03% | 368 |
|
|
2021
Q4 | $7.85M | Buy |
72,821
+1,203
| +2% | +$130K | 0.03% | 389 |
|
|
2021
Q3 | $7.84M | Buy |
71,618
+210
| +0.3% | +$23K | 0.03% | 376 |
|
|
2021
Q2 | $6.69M | Buy |
71,408
+550
| +0.8% | +$51.5K | 0.03% | 432 |
|
|
2021
Q1 | $6.52M | Buy |
+70,858
| New | +$6.52M | 0.03% | 409 |
|